MENU

ABOS Acumen Pharmaceuticals Forecast, Technical & Fundamental Analysis

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease... Show more

ABOS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
ABOS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ABOS is expected to report earnings to fall 15.33% to -38 cents per share on November 16

Acumen Pharmaceuticals ABOS Stock Earnings Reports
Q3'26
Est.
$-0.38
Q2'26
Missed
by $0.09
Q1'26
Beat
by $0.04
Q4'25
Beat
by $0.06
Q3'25
Beat
by $0.16
The last earnings report on August 12 showed earnings per share of -44 cents, missing the estimate of -36 cents. With 165.99K shares outstanding, the current market capitalization sits at 166.33M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
1210-1220 Washington Street
Phone
+1 617 344-4190
Employees
61
Web
https://www.acumenpharm.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QTEC333.663.93
+1.19%
First Trust NASDAQ-100 Technology Sector Index Fund (QTEC)
LYLD31.870.20
+0.64%
Cambria Large Cap Shareholder Yield ETF (LYLD)
RSST35.38-0.08
-0.21%
Return Stacked U.S. Stocks & Managed Futures ETF (RSST)
BKHY45.55-0.29
-0.63%
BNY Mellon High Yield ETF (BKHY)
SMU15.55-0.41
-2.57%
Tradr 2X Long SMR Daily ETF (SMU)

ABOS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with CCXI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then CCXI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-6.76%
CCXI - ABOS
48%
Loosely correlated
N/A
NKTX - ABOS
44%
Loosely correlated
-2.29%
RCKT - ABOS
44%
Loosely correlated
-1.52%
CRBU - ABOS
40%
Loosely correlated
-3.94%
EDIT - ABOS
39%
Loosely correlated
-1.95%
More
Acumen Pharmaceuticals (ABOS) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com